Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN272201700022C
IGF::OT::IGF NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN81 — AIDS RESEARCH - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $12.8M |
| Current contract value | $12.8M |
| Potential contract value / ceiling | $18.9M |
| Start date | Jun 1, 2017 |
| Current end date | May 31, 2024 |
| Potential end date | May 31, 2024 |
| Latest award activity | Sep 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 1, 2026 | P00012 | $-0 | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| Jun 25, 2024 | P00011 | $-1.3K | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| Aug 17, 2023 | P00010 | $1.9M | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| May 24, 2023 | P00009 | $0 | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| May 27, 2022 | P00008 | $-6.1K | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| May 9, 2022 | P00007 | $1.9M | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV I |
| Oct 22, 2021 | P00006 | $0 | EO14042 THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV |
| Mar 17, 2021 | P00005 | $1.8M | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV IN STUDIES C |
| May 26, 2020 | P00004 | $1.8M | THIS CONTRACT SHALL CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE CELLULAR IMMUNE RESPONSES OF NHP THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED WITH SIV, SHIV, OR HIV IN STUDIES C |
| Aug 27, 2019 | P00003 | $155.6K | R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) |
| May 22, 2019 | P00002 | $1.8M | IGF::OT::IGF NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT |
| May 30, 2018 | 1 | $1.7M | IGF::OT::IGF NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT |
| Jun 1, 2017 | 0 | $1.7M | IGF::OT::IGF NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.